H3N2 Mismatch of 2014-15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Xie, Hang ^a   Wan, Xiu Feng ^b   Ye, Zhiping ^a   Plant, Ewan P ^a   Zhao, Yangqing ^a   Xu, Yifei ^b   Li, Xing ^a   Finch, Courtney ^a   Zhao, Nan ^b   Kawano, Toshiaki ^a   Zoueva, Olga ^a   Chiang, Meng Jung ^a   Jing, Xianghong ^a   Lin, Zhengshi ^a   Zhang, Anding ^a   Zhu, Yanhong ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; HEMAGGLUTININ I; INFLUENZA VACCINE; LECTIN; VIRUS ANTIGEN;

ADULT; ANIMAL; CHEMISTRY; CHILD; CROSS REACTION; FERRET; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; METABOLISM; MOLECULAR MODEL; PROTEIN TERTIARY STRUCTURE; VACCINATION;

ADULT; ANIMALS; ANTIGENS, VIRAL; CHILD; CROSS REACTIONS; FERRETS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNE SERA; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LECTINS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; VACCINATION;

EID: 84944350893     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15279     Document Type: Article

References (44)

1. Flannery, B. et al. Early estimates of seasonal influenza vaccine effectiveness -United States, january 2015. MMWR Morb Mortal. Wkly Rep 64, 10-15 (2015).
2. DMello, T. et al. Update: Influenza Activity -United States, September 28, 2014-February 21, 2015. MMWR. Morb. Mortal. Wkly. Rep. 64, 206-212 (2015).
3. Skowronski, D. et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada s Sentinel Physician Surveillance Network, January 2015. Euro Surveill. 20, doi: 10.2807/1560-7917.ES2015.20.4.21022 (2015).
4. Barr, I. G. et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. Vaccine 28, 1156-1167 (2010).
5. Russell, C. A. et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26 Suppl 4, D31-D34 (2008).
6. Bush, R. M., Smith, C. B., Cox, N. J. & Fitch, W. M. Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc. Natl. Acad. Sci USA 97, 6974-6980 (2000).
7. Smith, D. J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376 (2004).
8. Hensley, S. E. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin. Virol. 8, 85-89 (2014).
9. Li, Y. et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp. Med 210, 1493-1500 (2013).
10. Xie, H. et al. Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS One 6, e16650 (2011).
11. Xie, H. et al. Revisiting the 1976 swine flu vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice. Clin. Infect. Dis. 53, 1179-1187 (2011).
12. Cai, Z., Zhang, T. & Wan, X. F. A computational framework for influenza antigenic cartography. PLoS Comput. Biol. 6, e1000949 (2010).
13. Barnett, J. L., Yang, J., Cai, Z., Zhang, T. & Wan, X. F. AntigenMap 3D: an online antigenic cartography resource. Bioinformatics 28, 1292-1293 (2012).
14. Feng, Z. et al. Antigenic characterization of H3N2 influenza A viruses from Ohio agricultural fairs. J Virol 87, 7655-7667 (2013).
15. Beato, M. S., Xu, Y., Long, L. P., Capua, I. & Wan, X. F. Antigenic and genetic evolution of low-pathogenicity avian influenza viruses of subtype H7N3 following heterologous vaccination. Clin Vaccine Immunol 21, 603-612 (2014).
16. Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J Mol. Biol. 234, 779-815 (1993).
17. Yang, H. et al. Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins. Virology 477C, 18-31 (2015).
18. Wiley, D. C., Wilson, I. A. & Skehel, J. J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 289, 373-378 (1981).
19. Wilson, I. A. & Cox, N. J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol 8, 737-771 (1990).
20. Kishida, N. et al. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol 19, 897-908 (2012).
21. Herrera, G. A. et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 25, 154-160 (2007).
22. Tricco, A. C. et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 11, 153 (2013).
23. Chambers, B. S., Parkhouse, K., Ross, T. M., Alby, K. & Hensley, S. E. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Rep 12, 1-6 (2015).
24. Munoz, E. T. & Deem, M. W. Epitope analysis for influenza vaccine design. Vaccine 23, 1144-1148 (2005).
25. Bush, R. M., Bender, C. A., Subbarao, K., Cox, N. J. & Fitch, W. M. Predicting the evolution of human influenza A. Science 286, 1921-1925 (1999).
26. Bush, R. M., Fitch, W. M., Bender, C. A. & Cox, N. J. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 16, 1457-1465 (1999).
27. Bragstad, K., Nielsen, L. P. & Fomsgaard, A. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol. J. 5, 40 (2008).
28. Skowronski, D. M. et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 9, e92153 (2014).
29. Chen, Z., Zhou, H. & Jin, H. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response. Vaccine 28, 4079-4085 (2010).
30. Jin, H. et al. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336, 113-119 (2005).
31. Popova, L. et al. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. PLoS One 7, e41895 (2012).
32. Koel, B. F. et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science. 342, 976-979 (2013).
33. Interim adjusted estimates of seasonal influenza vaccine effectiveness -United States, February 2013. MMWR Morb Mortal. Wkly Rep 62, 119-123 (2013).
34. Belser, J. A., Katz, J. M. & Tumpey, T. M. The ferret as a model organism to study influenza A virus infection. Dis. Model. Mech. 4, 575-579 (2011).
35. Fonville, J. M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996-1000 (2014).
36. Lee, M. S. & Yang, C. F. Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains. J Infect. Dis 188, 1362-1366 (2003).
37. Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp. Med 208, 181-193 (2011).
38. Li, G. M. et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci USA 109, 9047-9052 (2012).
39. Chen, Z. et al. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84, 44-51 (2010).
40. Abe, Y. et al. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78, 9605-9611 (2004).
41. Linderman, S. L. et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc. Natl. Acad. Sci USA 111, 15798-15803 (2014).
42. Potter, C. W., Shore, S. L., McLaren, C. & Stuart-Harris, C. Immunity to influenza in ferrets. II. Influence of adjuvants on immunization. Br. J Exp. Pathol. 53, 168-179 (1972).
43. McLaren, C., Potter, C. W. & Jennings, R. Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization. J Hyg. (Lond. ) 73, 389-399 (1974).
44. Dormitzer, P. R. et al. Influenza vaccine immunology. Immunol Rev 239, 167-177 (2011).